CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) EBITDA Margin (2016 - 2024)

Updated

CNBX Pharmaceuticals (CNBX) posted EBITDA Margin of -392.71% for FY2024 (year ended Aug 31, 2024), down 205.15 percentage points from -187.56% in FY2023.

Analysis

CNBX Pharmaceuticals Inc. (CNBX) EBITDA Margin (2016 - 2024) Analysis & Trends

Since FY2016, CNBX Pharmaceuticals has reported EBITDA Margin for 8 fiscal years.

  • Annual EBITDA Margin shows a five-year change of +31250.88 percentage points (FY2019 to FY2024).
  • Annual EBITDA Margin has run from a low of -39517.90% in FY2020 to a high of -187.56% in FY2023 over five years.
  • Business Quant data shows CNBX's EBITDA Margin at -187.56% in FY2023 (+9010.12 pp), -9197.69% in FY2022 and -39517.90% in FY2020 (-7874.30 pp).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Feb 29, 2024 -427.12%
Nov 30, 2023 -148.08%
Aug 31, 2023 -123.01%
May 31, 2023 -42.91%
Aug 31, 2022 -1,438.90%
Aug 31, 2020 -28,216.95%
May 31, 2020 -33,260.02%
Feb 29, 2020 -62,136.34%
Nov 30, 2019 -43,573.43%
Aug 31, 2019 -45,326.97%
May 31, 2019 -33,978.84%
Feb 28, 2019 -36,470.56%
Nov 30, 2018 -18,208.47%
Aug 31, 2018 -22,455.14%
May 31, 2018 -28,329.13%
Feb 28, 2018 -87,379.29%
Nov 30, 2017 -30,250.91%
Aug 31, 2017 -37,674.53%
May 31, 2017 -29,978.80%
Feb 28, 2017 -15,450.36%
API Access

CNBX Pharmaceuticals Inc. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNBX&period=max&api_key=YOUR_API_KEY